Literature DB >> 31495053

The ubiquitin ligase adaptor SPOP in cancer.

Matthew J Cuneo1, Tanja Mittag1.   

Abstract

The dysregulation of ubiquitin-mediated proteasomal degradation has emerged as an important mechanism of pathogenesis in several cancers. The speckle-type POZ protein (SPOP) functions as a substrate adaptor for the cullin3-RING ubiquitin ligase and controls the cellular persistence of a diverse array of protein substrates in hormone signalling, epigenetic control and cell cycle regulation, to name a few. Mutations in SPOP and the resulting dysregulation of this proteostatic pathway play causative roles in the pathogenesis of prostate and endometrial cancers, whereas overexpression and mislocalization are associated with kidney cancer. Understanding the molecular mechanism of the normal function of SPOP as well as the cause of SPOP-mediated oncogenesis is thus critical for eventual therapeutic targeting of SPOP and other related pathways. Here, we will review SPOP structure, function and the molecular mechanism of how this function is achieved. We will then review how mutations and protein mislocalization contribute to cancer pathogenesis and will provide a perspective on how SPOP may be targeted therapeutically.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  SPOP; endometrial cancer; intrinsically disordered proteins; liquid-liquid phase separation; prostate cancer; ubiquitin ligase; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31495053      PMCID: PMC6803047          DOI: 10.1111/febs.15056

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  57 in total

1.  The Structure of the SPOP-Pdx1 Interface Reveals Insights into the Phosphorylation-Dependent Binding Regulation.

Authors:  Michael Sebastian Ostertag; Ana Cristina Messias; Michael Sattler; Grzegorz Maria Popowicz
Journal:  Structure       Date:  2018-11-15       Impact factor: 5.006

2.  Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer.

Authors:  Chuandong Geng; Kimal Rajapakshe; Shrijal S Shah; John Shou; Vijay Kumar Eedunuri; Christopher Foley; Warren Fiskus; Mahitha Rajendran; Sue Anne Chew; Martin Zimmermann; Richard Bond; Bin He; Cristian Coarfa; Nicholas Mitsiades
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

3.  Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus.

Authors:  David Kent; Erik W Bush; Joan E Hooper
Journal:  Development       Date:  2006-05       Impact factor: 6.868

4.  Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.

Authors:  Zhong-Qiang Guo; Tong Zheng; Baoen Chen; Cheng Luo; Sisheng Ouyang; Shouzhe Gong; Jiafei Li; Liu-Liang Mao; Fulin Lian; Yong Yang; Yue Huang; Li Li; Jing Lu; Bidong Zhang; Luming Zhou; Hong Ding; Zhiwei Gao; Liqun Zhou; Guoqiang Li; Ran Zhou; Ke Chen; Jingqiu Liu; Yi Wen; Likun Gong; Yuwen Ke; Shang-Dong Yang; Xiao-Bo Qiu; Naixia Zhang; Jin Ren; Dafang Zhong; Cai-Guang Yang; Jiang Liu; Hualiang Jiang
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

5.  Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.

Authors:  Chuandong Geng; Bin He; Limei Xu; Christopher E Barbieri; Vijay Kumar Eedunuri; Sue Anne Chew; Martin Zimmermann; Richard Bond; John Shou; Chao Li; Mirjam Blattner; David M Lonard; Francesca Demichelis; Cristian Coarfa; Mark A Rubin; Pengbo Zhou; Bert W O'Malley; Nicholas Mitsiades
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-04       Impact factor: 11.205

6.  Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions.

Authors:  Thuy P Dao; Regina-Maria Kolaitis; Hong Joo Kim; Kevin O'Donovan; Brian Martyniak; Erica Colicino; Heidi Hehnly; J Paul Taylor; Carlos A Castañeda
Journal:  Mol Cell       Date:  2018-03-08       Impact factor: 17.970

7.  Sequence and structural analysis of BTB domain proteins.

Authors:  Peter J Stogios; Gregory S Downs; Jimmy J S Jauhal; Sukhjeen K Nandra; Gilbert G Privé
Journal:  Genome Biol       Date:  2005-09-15       Impact factor: 13.583

8.  SPOP mutation leads to genomic instability in prostate cancer.

Authors:  Gunther Boysen; Christopher E Barbieri; Davide Prandi; Mirjam Blattner; Sung-Suk Chae; Arun Dahija; Srilakshmi Nataraj; Dennis Huang; Clarisse Marotz; Limei Xu; Julie Huang; Paola Lecca; Sagar Chhangawala; Deli Liu; Pengbo Zhou; Andrea Sboner; Johann S de Bono; Francesca Demichelis; Yariv Houvras; Mark A Rubin
Journal:  Elife       Date:  2015-09-16       Impact factor: 8.140

9.  Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.

Authors:  Xiaofeng Jin; Jie Wang; Kun Gao; Pingzhao Zhang; Longfang Yao; Yan Tang; Lisha Tang; Jian Ma; Jiantao Xiao; Enceng Zhang; Jie Zhu; Bin Zhang; Shi-Min Zhao; Yao Li; Shancheng Ren; Haojie Huang; Long Yu; Chenji Wang
Journal:  PLoS Genet       Date:  2017-04-27       Impact factor: 5.917

10.  The Pfam protein families database in 2019.

Authors:  Sara El-Gebali; Jaina Mistry; Alex Bateman; Sean R Eddy; Aurélien Luciani; Simon C Potter; Matloob Qureshi; Lorna J Richardson; Gustavo A Salazar; Alfredo Smart; Erik L L Sonnhammer; Layla Hirsh; Lisanna Paladin; Damiano Piovesan; Silvio C E Tosatto; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  9 in total

1.  SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship.

Authors:  Qing Zhu; Guanghui Zhang; Mingyang Tang; Rumin Zheng; Huaiyong Gan
Journal:  Appl Bionics Biomech       Date:  2022-04-15       Impact factor: 1.664

2.  Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity.

Authors:  Emery T Usher; Nafiseh Sabri; Roman Rohac; Amie K Boal; Tanja Mittag; Scott A Showalter
Journal:  J Biol Chem       Date:  2021-04-21       Impact factor: 5.157

3.  The human GID complex engages two independent modules for substrate recruitment.

Authors:  Weaam I Mohamed; Sophia L Park; Julius Rabl; Alexander Leitner; Daniel Boehringer; Matthias Peter
Journal:  EMBO Rep       Date:  2021-10-14       Impact factor: 8.807

4.  OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.

Authors:  Xuhong Fu; Junjie Zhao; Guopeng Yu; Xiaomin Zhang; Jie Sun; Lingmeng Li; Jingyi Yin; Yinan Niu; Shancheng Ren; Yasheng Zhu; Bin Xu; Liyu Huang
Journal:  Commun Biol       Date:  2022-03-01

5.  Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer.

Authors:  Wei Li; Zhe Lu; Dongqing Pan; Zejian Zhang; Hua He; Jiacheng Wu; Naixiong Peng
Journal:  J Oncol       Date:  2022-07-06       Impact factor: 4.501

6.  A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Authors:  Kazuki Tawaratsumida; Vanessa Redecke; Ruiqiong Wu; Jeeba Kuriakose; Jill J Bouchard; Tanja Mittag; Brian K Lohman; Ashutosh Mishra; Anthony A High; Hans Häcker
Journal:  Sci Adv       Date:  2022-07-08       Impact factor: 14.957

7.  SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization.

Authors:  Jiangchun Wu; Yong Wu; Qinhao Guo; Xiaohua Wu; Jun Zhu; Xingzhu Ju; Siyu Chen; Simin Wang
Journal:  J Transl Med       Date:  2022-08-30       Impact factor: 8.440

Review 8.  The Roles of SPOP in DNA Damage Response and DNA Replication.

Authors:  Masashi Maekawa; Shigeki Higashiyama
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

9.  c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.

Authors:  Lan Zhang; Xiaohui Wang; Yunfei Li; Jing Han; Xianzheng Gao; Shenglei Li; Feng Wang
Journal:  Clin Transl Med       Date:  2021-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.